Literature DB >> 19160540

The IKK-related kinases: from innate immunity to oncogenesis.

Jean-François Clément1, Sylvain Meloche, Marc J Servant.   

Abstract

Over the past four years, the field of the innate immune response has been highly influenced by the discovery of the IkappaB kinase (IKK)-related kinases, TANK Binding Kinase 1 (TBK1) and IKKi, which regulate the activity of interferon regulatory factor (IRF)-3/IRF-7 and NF-kappaB transcription factors. More recently, additional essential components of the signaling pathways that activate these IKK homologues have been discovered. These include the RNA helicases RIGi and MDA5, and the downstream mitochondrial effector known as CARDIF/MAVS/VISA/IPS-1. In addition to their essential functions in controlling the innate immune response, recent studies have highlighted a role of these kinases in cell proliferation and oncogenesis. The canonical IKKs are well recognized to be a bridge linking chronic inflammation to cancer. New findings now suggest that the IKK-related kinases TBK1 and IKKi also participate in signaling pathways that impact on cell transformation and tumor progression. This review will therefore summarize and discuss the role of TBK1 and IKKi in cellular transformation and oncogenesis by focusing on their regulation and substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19160540     DOI: 10.1038/cr.2008.273

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  97 in total

1.  TANK-binding kinase 1 attenuates PTAP-dependent retroviral budding through targeting endosomal sorting complex required for transport-I.

Authors:  Qi Da; Xuanming Yang; Youli Xu; Guangxia Gao; Genhong Cheng; Hong Tang
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 2.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

3.  Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.

Authors:  Bokyung Sung; Sung-Gook Cho; Mingyao Liu; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

4.  Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis.

Authors:  Francis S Wolenski; Michael R Garbati; Tristan J Lubinski; Nikki Traylor-Knowles; Erica Dresselhaus; Derek J Stefanik; Haley Goucher; John R Finnerty; Thomas D Gilmore
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

Review 5.  Activation of RIG-I-like receptor signal transduction.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-11-08       Impact factor: 8.250

6.  Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Authors:  Sarah L Doyle; Kari Ann Shirey; Anne F McGettrick; Elaine F Kenny; Susan Carpenter; Brian E Caffrey; Siobhan Gargan; Susan R Quinn; Jorge H Caamaño; Paul Moynagh; Stefanie N Vogel; Luke A O'Neill
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

7.  Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

Authors:  Ryan D Morin; Karen Mungall; Erin Pleasance; Andrew J Mungall; Rodrigo Goya; Ryan D Huff; David W Scott; Jiarui Ding; Andrew Roth; Readman Chiu; Richard D Corbett; Fong Chun Chan; Maria Mendez-Lago; Diane L Trinh; Madison Bolger-Munro; Greg Taylor; Alireza Hadj Khodabakhshi; Susana Ben-Neriah; Julia Pon; Barbara Meissner; Bruce Woolcock; Noushin Farnoud; Sanja Rogic; Emilia L Lim; Nathalie A Johnson; Sohrab Shah; Steven Jones; Christian Steidl; Robert Holt; Inanc Birol; Richard Moore; Joseph M Connors; Randy D Gascoyne; Marco A Marra
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

Review 8.  Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.

Authors:  Maroof Hasan; Nan Yan
Journal:  Pharmacol Res       Date:  2016-06-25       Impact factor: 7.658

9.  Pyroglutamylated RF-amide peptide (QRFP) gene is regulated by metabolic endotoxemia.

Authors:  Christian Jossart; Mukandila Mulumba; Riccarda Granata; Davide Gallo; Ezio Ghigo; Sylvie Marleau; Marc J Servant; Huy Ong
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 10.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.